Bonava AB (publ) (BONAV-B)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 8.390 |
|---|---|
| 52-week range | 7.950 – 13.620 |
| Return, 1 month / 3 months | −7.3% / −14.8% |
| Return, 1 year / 3 years | −23.7% / −12.3% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 35.5% |
| Worst drawdown (1 year) | -39.8% |
| Average daily value traded | 5.41M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bonava is a residential property developer based in Sweden that builds homes for private buyers. The company develops and constructs apartments, terraced houses and similar housing, and it also handles the sale of the finished homes to individual customers. Its operations span several countries in northern Europe and the Baltic region, where it works on projects from land acquisition through construction to handover. Bonava focuses on housing for ordinary households rather than commercial property.
The shares are listed on the Stockholm Exchange in Sweden under the code BONAV-B, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bonava AB (publ) (BONAV-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 8.390 on 19 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 475 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 23.7% and over the last three months it fell 14.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 36 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.4% | ||
| From 52-week high | -37.9% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.8% | ||
| 6-month return | -10.1% | ||
| 12-month return, skipping the last month | -17.7% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.8% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 5.41M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.8% |
|---|---|
| 1 month | −7.3% |
| 3 months | −14.8% |
| 6 months | −10.1% |
| 1 year | −23.7% |
| 3 years | −12.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 9.359 / 9.918 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.284 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Sep 2022 | SEK 0.9976 |
| 4 Apr 2022 | SEK 0.9976 |
| 1 Oct 2021 | SEK 0.9121 |
| 1 Apr 2021 | SEK 2.0807 |
| 30 Sep 2020 | SEK 1.5000 |
| 1 Apr 2020 | SEK 1.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.